My Take: FDX is a classic stock that could be a great addition to many portfolios. However, it's a slow mover, so don't expect to see any explosive moves higher.
Calliditas Therapeutics [CALT] - Last Close: $16.38
Calliditas Therapeutics is heating up ahead of a big event.
Earlier this week, the micro-cap pharma firm said it would present new drug data at an upcoming conference in Tokyo running from Sept. 25th to 27th.
Calliditas will share new data for its nefecon treatment at the event, called the 17th International Symposium on IgA Nephropathy.
Shares of CALT have been trading somewhat erratically since the announcement, but it's up 16.0% in today's premarket.
My Take: There might be more to this story, but it seems like CALT is moving higher in anticipation of this upcoming conference, which could prove to be a catalyst for this low-float stock.
Murphy Canyon Acquisition [MURF] - Last Close: $12.84
Shareholders just voted to approve Murphy Canyon's merger plan.
Wednesday morning, the SPAC announced shareholders had voted to approve its pending merger with Conduit Pharmaceuticals.
Murphy Canyon SPAC says it expects to close on the deal "as soon as possible."
Upon closing, the combined company will change its name to Conduit Pharmaceuticals and trade under the ticker symbol CDT.
MURF is one of the morning's top stocks with a 32.7% gain.
My Take: I don't know enough about Conduit Pharma to gauge its long-term outlook, but I'd wager that most of the good news regarding the merger approval is already priced into MURF at this point.
Near Intelligence [NIR] - Last Close: $0.2090
Near Intelligence is climbing after an early-morning press release.
The company published a note highlighting its involvement in the global commercial real estate (CRE) industry.
Near Intelligence said its CRE clients account for a combined revenue of nearly $87 billion, with upwards of $200 billion in assets under management.
The press release also included several company resources regarding its CRE business, as well as case studies exploring cutting-edge CRE trends.
NIR is up 48.8% in the wake of the announcement.
My Take: NIR's latest press release seems like a puff piece with not a lot of substance to it. I'm not sure why the market is reacting so strongly to this news.
